Human Genome Sciences, Inc is seeking approval for albinterferon alfa-2b (Zalbin) for the treatment of chronic hepatitis C.
You can subscribe by email to receive newsletter updates:
Subscribe through a RSS feed reader
News Feed Comments Feed